Our Team

Carly recently joined Harvard’s Office of Technology Development (OTD) as Alliance Director, where she will lead operations of the Corporate Alliances team and oversee the Alliance portfolio. Carly was previously part of OTD’s Corporate Alliances team for many years, where she helped establish and managed numerous multi-program alliances with different industry partners. Before returning to OTD as Alliance Director, Carly spent time as an Alliance Manager at Arrowhead Pharmaceuticals, a mid-sized biotech company developing RNAi therapeutics. At Arrowhead, Carly managed the company’s partnership and joint venture portfolio, comprised of multiple assets in various therapeutic areas and stages of clinical development.

Carly is a certified Alliance Management professional (CA-AM) and formally trained biochemist, whose research focused on unraveling novel transcriptional and signaling mechanisms driving insulin resistance, diabetes and metabolic syndrome. Carly completed her postdoctoral training at the Joslin Diabetes Center and Harvard Medical School, while also participating as a Business Development Fellow at OTD. Carly holds a BS in biology from Syracuse University, and a PhD in biochemistry, cell and molecular biology from Boston University School of Medicine.